Adcock Ingram Delisting After Natco Acquisition
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
Adcock Ingram Takeover Gets Green Light from Shareholders
Shareholders have approved the Adcock Ingram takeover by Natco Pharma, marking a new chapter for the pharmaceutical company.
Adcock Ingram Reports Flat Profit Despite Winter Surge
Adcock Ingram reports steady annual profits as winter demand for Panado and Corenza-C drives growth in the second half.
Bidvest’s Role in Adcock Ingram Takeover Bid
Learn how Bidvest's partnership with Natco Pharma impacts Adcock Ingram and shareholder rights amid a new takeover bid.
Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.